Filing Details
- Accession Number:
- 0001571049-17-001290
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-13 20:33:36
- Reporting Period:
- 2017-02-09
- Filing Date:
- 2017-02-13
- Accepted Time:
- 2017-02-13 20:33:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069899 | Phibro Animal Health Corp | PAHC | Pharmaceutical Preparations (2834) | 131840497 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601340 | G Thomas Dagger | 300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 07666-6712 | Svp, Gen Counsel And Corp Secr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2017-02-09 | 3,993 | $11.83 | 3,993 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2017-02-09 | 1,900 | $11.83 | 5,893 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2017-02-09 | 5,893 | $30.27 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Option to purchase Class A Common Stock | Disposition | 2017-02-09 | 5,893 | $0.00 | 3,993 | $11.83 |
| Class A Common Stock | Option to purchase Class A Common Stock | Disposition | 2017-02-09 | 1,900 | $0.00 | 1,900 | $11.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-03-01 | 2019-02-28 | No | 4 | M | Direct |
| 9,150 | 2013-03-01 | 2019-02-28 | No | 4 | M | Direct |
Footnotes
- Reflects conversions of options with an exercisable date of March 1, 2012.
- Reflects conversion of options with an exercisable date of March 1, 2013.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.45.
Billionaire Hedge Funds
